Delivery Order SPE2DB25D3008-SPE2DB25FRDBF
- Not listed
- The Defense Logistics Agency awarded a $1,878.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pen injectors (0.5 mL units) on August 19, 2025, with completion scheduled for August 20, 2025. This competitive award, with no set-aside designation, represents a child delivery order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at approximately $1 billion through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen injections, with a ceiling value of $3,658.05. This is a firm fixed-price delivery order with an ultimate completion date of July 16, 2025, and no set-aside designation was applied. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pen injectors valued at $12,590.49. This non-competitive, firm fixed-price delivery order is expected to be completed by August 19, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen injectors, valued at $2,775.42 with a firm fixed price. The award was made on July 29, 2025, with an ultimate completion date of July 30, 2025, and represents a non-set-aside, competitively awarded contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $3,453.76 delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen injectors (0.5 mL units) with an ultimate completion date of July 31, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $4,448.56 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen injectors (0.5 ml units). This competitively awarded, firm fixed-price contract is classified as a non-set-aside procurement and carries an ultimate completion date of September 2, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,194.83 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen injectors. This firm fixed price delivery order was competitively awarded without set-aside designation and is scheduled for completion by May 21, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location and deliver this diabetes medication as part of federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $5,322.32 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen injectors (0.5 mL units). This competitively awarded, firm fixed-price delivery order was issued on June 18, 2025, with an ultimate completion date of June 20, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Trulicity 4.5 mg/0.5 ml pen injectors with a firm fixed price ceiling value of $2,644.53 and an ultimate completion date of July 22, 2025. This is a non-set-aside competitive award executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vehicle running through December 2026 that supports global...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,076.73 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen injectors on September 9, 2025, with an ultimate completion date of September 10, 2025. This non-set-aside, firm fixed-price delivery order represents a competitive award to support federal medical procurement needs. The contract specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its...
- SPE2DB25D3008Indefinite Delivery Contract
- SPE2DB25D3008-SPE2DB25FRDBFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen injectors valued at $2,402.10. This firm fixed-price delivery order, which was competitively awarded without set-aside designation, is scheduled for completion by August 26, 2025, just one day after the award date of August 25, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion and running through December 2026. This parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor serving military and veteran healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to meet federal procurement requirements through open competition, supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The delivery order will be fulfilled from the company's Conshohocken, Pennsylvania location, continuing AmerisourceBergen's role as a key supplier to the Defense Health Agency and other government healthcare systems through the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 8/25/25 |